Columbia Laboratories, Inc. (Nasdaq:CBRX) today announced that its Board
of Directors has appointed three experienced healthcare executives with
over 65 years collective industry experience to its Board of Directors,
...

Columbia Laboratories, Inc. (NasdaqCM:CBRX) received notice on August
23, 2012, from the Nasdaq Stock Market that the Company has regained
compliance with the Nasdaq Stock Market minimum bid price requirement as
set...

Columbia Laboratories, Inc. (Nasdaq: CBRX) (the “Company”) today
announced that its Board of Directors on March 1, 2013 adopted an
amendment to its Stockholder Rights Plan (the "Rights Plan"), originally
...

Columbia Laboratories Inc. (Nasdaq: CBRX) (the “Company”) received a
letter on October 24, 2012, from the Nasdaq Stock Market indicating that
the Company no longer meets the minimum bid price requirement for
...

Columbia Laboratories Inc. (Nasdaq: CBRX) received a notice on September
6, 2012, from the Nasdaq Stock Market indicating that the Company has
regained compliance with the minimum bid price requirement for continued
...